Subscribe to Newsletter

Quality & Compliance

Business & Regulation Standards & Regulation

EFPIA Calls For Clarity Over JCA Concerns

| Rob Coker | 2 min read

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

Business & Regulation Digital Technologies

AI and the Copyright Question for R&D

| Rob Coker | 2 min read

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

Manufacture Facilities

Ambition, Innovation, Impact: The Future of Cleanroom Standards

| 5 min read

The rocket-fueled dreams of a young engineer applied to the cleanroom industry.

Business & Regulation Standards & Regulation

FDA Warning Letters: September 2024 Edition

| Stephanie Vine | 3 min read

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

Manufacture Contract Manufacturing Services

Ready for Anything

| Rob Coker

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Manufacture Quality & Compliance

Facing Up to the New Nemesis of Pharma: Nitrosamines

| 8 min read

What’s going on with nitrosamines? Naiffer Romero from the USP walks us through frequently asked questions.

Manufacture Technology and Equipment

An Analytical Eye for mRNA

| 5 min read

How a new collaboration looks to improve analytical testing for mRNA products.

Business & Regulation Business Practice

Counterfeit Medicines: Getting On The Right Track

| 5 min read

Counterfeit deterrents are not yet available in some regions. We speak with Advanco CEO Alf Goebel to find out why.

Manufacture Quality & Compliance

Manufacturing a Better Future

| 2 min read

What does sustainability look like at Cytiva?

Discovery & Development Ingredients

USP: A Mission Focused on Quality and Safety

| Chaitanya Koduri | 11 min read

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.


Latest White Papers

Overcoming the challenges of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

HRAM LC-MS method for the determination of nitrosamine impurities in drugs

| Contributed by Thermo Fisher Scientific

LC-MS/MS method for the quantification of 10 nitrosamine impurities in metformin

| Contributed by Thermo Fisher Scientific

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register